US panel backs first-of-a-kind COVID-19 pill from Merck

Nov 29, 2021, 4:10 PM | Updated: Nov 30, 2021, 4:40 pm
FILE - This undated file image provided by Merck & Co. shows their new antiviral medication molnupi...

FILE - This undated file image provided by Merck & Co. shows their new antiviral medication molnupiravir. An experimental COVID-19 drug that could soon become the first U.S.-authorized pill to treat the coronavirus faces one final hurdle Tuesday: A panel of government experts will scrutinize data on the medication from drugmaker Merck. (Merck & Co. via AP, File)

(Merck & Co. via AP, File)

WASHINGTON (AP) — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.

The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy.

“I see this as an incredibly difficult decision with many more questions than answers,” said panel chair Dr. Lindsey Baden of Harvard Medical School, who voted in favor of the drug. He said FDA would have to carefully tailor the drug’s use for patients who stand to benefit most.

The recommendation came after hours of debate about the drug’s modest benefits and potential safety issues. Most experts backing the treatment stressed that it should not be used by anyone who is pregnant and called on FDA to recommend extra precautions before the drug is prescribed, such as pregnancy tests for women of child-bearing age.

The vote specifically backed the drug for adults with mild-to-moderate COVID-19 who face the greatest risks, including older people and those with conditions like obesity and asthma. Most experts also said the drug shouldn’t be used in vaccinated people, who weren’t part of Merck’s research and haven’t been shown to benefit.

The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision before year’s end. The antiviral is already authorized in the U.K.

The drug, molnupiravir, could provide a much-needed weapon against the virus as colder weather pushes case counts higher and U.S. officials brace for the arrival of the new omicron variant.

Merck hasn’t specifically tested its drug against the new variant but said it should have some potency based on its effectiveness against other strains of coronavirus.

That uncertainty frustrated many panelists as they grappled with whether to back the treatment for millions of Americans.

“With no data saying it works with new variants, I really think we need to be careful about saying that this is the way to go,” said Dr. David Hardy of Charles Drew University School of Medicine and Science, who ultimately voted to back the drug.

On Friday, Merck released updated data that paint a less compelling picture of the drug’s effectiveness than just a few weeks earlier.

Merck said final study results showed molnupiravir reduced hospitalization and death by 30% among adults infected with the coronavirus, when compared with adults taking a placebo. That effect was significantly less than the 50% reduction it first announced based on incomplete results.

For many panelists, the modest effect wasn’t enough to outweigh the drug’s potential toxicity to human fetuses.

“Given the large potential population affected, the risk of widespread effects on potential birth defects has not been adequately studied,” said Dr. Sankar Swaminathan of the University of Utah School of Medicine, who voted against the drug.

FDA scientists told the panelists earlier Tuesday that company studies in rats showed the drug caused birth defects when given at very high doses. FDA staffers concluded the data “suggest that molnupiravir may cause fetal harm when administered to pregnant individuals.”

The agency is weighing a blanket restriction against any use in pregnant women or allowing doctors to use the drug in rare cases. Some panelists said that option should be left open for pregnant mothers who have high-risk COVID-19 and may have few other treatment options.

Dr. Janet Cragan, who backed the drug, said that even with tight restrictions some pregnant women would inevitably take the antiviral.

“I don’t think you can ethically tell a woman with COVID-19 that she can’t have the drug if she’s decided that’s what she needs,” said Cragan, a panel member and staffer with the Centers for Disease Control and Prevention. “I think the final decision has to come down to the individual woman and her provider.”

Merck’s drug uses a novel approach to fight COVID-19: It inserts tiny errors into the coronavirus’ genetic code to stop it from reproducing. That genetic effect has raised concerns that the drug could spur more virulent strains of the virus. FDA regulators said Tuesday that risk is theoretical but many panelists said it should be carefully tracked in follow-up studies.

Antiviral pills have long been seen as a key advance beyond currently used antibody drugs, which must be injected or infused by health professionals. But given the shortcomings of Merck’s data, several experts said they would prioritize patients to receive the older drugs.

While Merck and its partner Ridgeback Biotherapeutics were the first to submit their COVID-19 pill to the FDA, rival drugmaker Pfizer is close behind with its own pill under review.

Pfizer’s drug is part of a decades-old family of antiviral pills known as protease inhibitors, a standard treatment for HIV and hepatitis C. They work differently than Merck’s pill and haven’t been linked to the kind of mutation concerns raised with Merck’s drug.

Pfizer said this week that its drug shouldn’t be affected by the omicron variant’s mutations.

Both drugs require patients to take multiple pills, twice a day for five days.

The U.S. government has agreed to purchase 10 million treatment courses of Pfizer’s drug, if it’s authorized. That’s more than three times the government’s purchase agreement with Merck for 3.1 million courses of molnupiravir.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Representatives of the Taliban arrive in Gardermoen, Norway, Saturday, Jan. 22, 2022.  A Taliban de...
Associated Press

Talks with Taliban begin in Norway

OSLO, Norway (AP) — A Taliban delegation led by acting Foreign Minister Amir Khan Muttaqi on Sunday started three days of talks with Western government officials and Afghan civil society representatives in Oslo amid a deteriorating humanitarian situation in Afghanistan. The closed-door meetings are taking place at a hotel in the snow-capped mountains above the […]
1 day ago
Associated Press

Heavy gunfire reported at Burkina Faso military base

OUAGADOUGOU, Burkina Faso (AP) — Heavy gunfire rang out at a military base in Burkina Faso’s capital early Sunday, prompting fears that a coup attempt was underway after weeks of growing frustration with the government’s handling of the Islamic insurgency wracking the country. The government put out a statement acknowledging gunfire in army barracks but […]
1 day ago
Associated Press

Turkish journalist jailed before trial for Erdogan insult

ISTANBUL (AP) — A well-known Turkish journalist has been jailed pending a trial for insulting President Recep Tayyip Erdogan, her lawyer said. Sedef Kabas was taken into custody after she cited a proverb on television and social media referring to an ox. Under the insult law, tens of thousands have been prosecuted for targeting Erdogan […]
1 day ago
Members of Ukraine's Territorial Defense Forces, volunteer military units of the Armed Forces, trai...
Associated Press

Russia rejects UK claim of trying to replace Ukraine leader

MOSCOW (AP) — Russia’s Foreign Ministry on Sunday rejected a British claim that Russia was seeking to replace Ukraine’s government with a pro-Moscow administration, and that former Ukrainian lawmaker Yevheniy Murayev was being considered as a potential candidate. Britain’s Foreign Office on Saturday also named several other Ukrainian politicians it said had links with Russian […]
1 day ago
A villager, dressed in a traditional bear costume, celebrates the Malanka festival in the village o...
Associated Press

AP PHOTOS: Ukrainians observe pagan-rooted new year festival

KRASNOILSK, Ukraine (AP) — Dressed as goats, bears, oxen and cranes, many Ukrainians ring in the new year in the colorful rituals of the Malanka holiday. Malanka, which draws on pagan folk tales, marks the new year according to the Julian calendar, meaning it falls on Jan. 13-14. In the festivities, celebrants go from house […]
1 day ago
A man repairs a 10-meter wooden row boat, built in the Nordic clinker boat tradition, at the Viking...
Associated Press

UNESCO lists Viking-era wooden sailboats on heritage list

ROSKILDE, Denmark (AP) — For thousands of years, wooden sailboats allowed the peoples of Northern Europe to spread trade, influence and sometimes war across seas and continents. In December, the U.N.’s culture agency added Nordic “clinker boats” to its list of traditions that represent the Intangible Cultural Heritage of Humanity. Denmark, Finland, Iceland, Norway and […]
1 day ago

Sponsored Articles

...

Compassion International Is Determined to ‘Fill’ a Unique Type of Football ‘Stadium’

Compassion International SPONSORED — During this fall’s football season—and as the pandemic continues to impact the entire globe—one organization has been urging caring individuals to help it “fill” a unique type of “stadium” in order to make a lasting difference in the lives of many. Compassion International’s distinctive Fill the Stadium (FtS, fillthestadium.com) initiative provides […]
...

What are the Strongest, Greenest, Best Windows?

Lake Washington Windows & Doors SPONSORED — Fiberglass windows are an excellent choice for window replacement due to their fundamental strength and durability. There is no other type of window that lasts as long as fiberglass; so why go with anything else? Fiberglass windows are 8x stronger than vinyl, lower maintenance than wood, more thermally […]
...

COVID Vaccine is a Game-Changer for Keeping our Kids Healthy

Snohomish Health District SPONSORED — Cheers to the parents and guardians who keep their kids safe and healthy. The dad who cooks a meal with something green in it, even though he’s tired and drive-thru burgers were tempting. The mom who calms down the little one who loudly and resolutely does NOT want to brush […]
...
Experience Anacortes

Coastal Christmas Celebration Week in Anacortes

With minimal travel time required and every activity under the sun, Anacortes is the perfect vacation spot for all ages.
...

Delayed-Onset PTSD: Signs and Symptoms

Lakeside-Milam Recovery Centers SPONSORED — You’re probably familiar with post-traumatic stress disorder. Often abbreviated as PTSD, this condition is diagnosed when a person experiences a set of symptoms for at least a month after a traumatic event. However, for some people, these issues take longer to develop. This results in a diagnosis of delayed-onset PTSD […]
...

Medicare open enrollment ends Dec. 7. Free unbiased help is here!

Washington State Office of the Insurance Commissioner SPONSORED — Medicare’s Open Enrollment Period, also called the Annual Election Period, is Oct. 15 to Dec. 7. During this time, people enrolled in Medicare can: Switch from Original Medicare to a Medicare Advantage plan and vice versa. Join, drop or switch a Part D prescription drug plan, […]
US panel backs first-of-a-kind COVID-19 pill from Merck